Kev Tshawb Fawb Kev Tshawb Fawb Txog Tirzepatide Hauv Kev Kho Mob Ntshav Qab Zib Hom 2

Kev tshawb fawb soj ntsuam kev nce qib ntawm Tirzepatide hauv kev kho mob ntshav qab zib hom 2

 

Tirzepatide, tshuaj tiv thaiv hyperglycemic tshiab, tau siv thoob ntiaj teb los txhim kho cov ntshav qab zib hauv cov neeg laus uas muaj ntshav qab zib hom 2. Thaum Lub Tsib Hlis 21, 2024, Tuam Tshoj National Medical Products Administration tau pom zoo daim ntawv thov kev lag luam ntawm tirzepatide rau kev kho mob ntshav qab zib hom 2. Qhov kev pom zoo no yog ua raws li cov txiaj ntsig zoo ntawm SURPASS series ntawm kev tshawb fawb thiab Theem III SURPASS-AP-Combo txoj kev tshawb fawb.

Nyob rau hauv SURPASS series ntawm kev tshawb fawb, tirzepatide tau pom cov txiaj ntsig tseem ceeb hauv ntshav qab zib. Piv txwv li, hauv SURPASS-1 txoj kev tshawb no, kev kho mob monotherapy nrog tirzepatide txo qis glycated hemoglobin (HbA1c) qib, thiab piv nrog insulin glargine, nws ua rau qhov hnyav dua. Tsis tas li ntawd, kev nyab xeeb thiab kev zam ntawm tirzepatide kuj tau lees paub hauv cov kev tshawb fawb.

Kev pom zoo ntawm tirzepatide muab kev kho mob tshiab rau cov neeg mob ntshav qab zib hom 2, tshwj xeeb tshaj yog rau cov neeg uas xav tau txo cov ntshav qab zib thiab qhov hnyav.

GenoHope Biotech Co., Ltd.
Ib lub tuam txhab ua lag luam ntawm GLP-1 API
Pom zoo los ntawm FDA
Zoo siab txais tos txhua qhov kev nug
WhatsApp / Tel: +8613833133635
Email:info@genohopebio.com